O. Sanli | Semantic Scholar

O. Sanli, J. Dobruch, Y. Lotan
Medicine, Biology
Nature Reviews Disease Primers
1 April 2020

For non-muscle-invasive bladder cancer (NMIBC), intravesical therapies with maintenance are the main treatments to prevent recurrence and progression after initial TURBT; additional therapies are needed for those who do not respond to BCG.

View on Nature

Manganese superoxide dismutase Ile58Thr, catalase C‐262T and myeloperoxidase G‐463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease

T. Tefik, C. Kucukgergin, O. Sanli, T. Oktar, Ş. Seçkin, C. Ozsoy
Biology, Medicine
BJU international
1 August 2013

To evaluate the relationship between manganese superoxide dismutase (MnSOD) Ile58Thr, catalase (CAT) C‐262T and myeloperoxidase (MPO) G‐463A gene polymorphisms and the susceptibility and…

View on Wiley

Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics.

S. Erdem, A. Amasyali, O. Aytac, Kadir Onem, H. Issever, O. Sanli
Medicine
Urologic oncology
1 October 2014

View on PubMed

Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma.

Y. Ozluk, D. Taheri, G. Netto
Biology, Medicine
Human pathology
1 December 2015

View on PubMed

Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer

Y. Şanlı, S. Kuyumcu, C. Turkmen
Medicine
Annals of Nuclear Medicine
12 September 2017

68Ga-PSMA PET/CT was found to be an effective tool for the detection of recurrent PCa and serum total PSA values may be used for estimating the likelihood of positive 68Ga- PSMA PET-CT results.

View on Springer

Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma.

M. Erdem, S. Erdem, D. Telci
Medicine
Urologic oncology
2014

View on PubMed

Genetic variants of MnSOD and GPX1 and susceptibility to bladder cancer in a Turkish population

C. Kucukgergin, O. Sanli, A. Amasyali, T. Tefik, Ş. Seçkin
Biology
Medical Oncology
1 September 2012

The present study indicates that the GPX1 Pro198Leu polymorphism may be associated with the risk and development of invasive bladder cancer, and the combination of the MnSOD Ala/Ala and GPx1 Leu/Leu genotypes may have a synergistic effect on disease risk.

View on Springer

The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.

C. Kucukgergin, F. Isman, Ş. Seçkin
Biology
Gene
10 December 2012

View on PubMed

Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.

C. Kucukgergin, F. Isman, B. Cakmakoglu, O. Sanli, Ş. Seçkin
Biology, Medicine
DNA and cell biology
31 July 2012

The data indicate that gene polymorphism of CCR2 V64I may influence the susceptibility and clinicopathological characteristics of prostate cancer and CCR5 Δ32 allele may also be an important risk factor for prostate cancer in Turkish men population.

View on PubMed

Validating the predictors of outcomes after radical cystectomy for bladder cancer

S. Woldu, O. Sanli, Timothy N. Clinton, Y. Lotan
Medicine
Cancer
6 October 2018

The modified Frailty Index has been proposed as a risk‐stratification tool for radical cystectomy (RC), and the objective of the current study was to validate this potential use of the mFI using an institutional cohort.

View on Wiley